NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
HeartBeam's Global Recognition in Portable ECG Technology: Key Questions Answered
TL;DR
HeartBeam ranked second globally in ECG innovation, positioning investors and partners for advantage in the rapidly growing remote cardiac diagnostics market.
HeartBeam's proprietary system captures heart signals in three dimensions and synthesizes them into a 12-lead ECG for remote cardiac monitoring.
HeartBeam's portable ECG technology enables better cardiac care access worldwide, improving early detection and treatment outcomes for heart patients.
HeartBeam beat 241 other companies to rank second globally in ECG innovation, trailing only GE Healthcare in portable cardiac diagnostics.
Found this article helpful?
Share it with your network and spread the knowledge!
HeartBeam was recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics and ranked second worldwide in 12-lead ECG innovation among 243 companies evaluated in PatentVest's "Total Cardiac Intelligence" report.
The ranking underscores the rapid maturation of HeartBeam's proprietary synthesis-ECG system and highlights the company's growing influence in the next generation of cardiac monitoring technology, with only GE Healthcare ranking higher.
The system captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG, allowing physicians to obtain comprehensive cardiac data through a portable device.
The HeartBeam System is a portable non-invasive recorder that records, stores, and transfers a patient's 3-Lead ECG acquired from 5 electrodes, intended for use by adult patients in clinical settings or at home for manual interpretation of non-life-threatening arrhythmias by healthcare professionals.
The latest news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT.
HeartBeam's intellectual property foundation was cited as a major reason for its high placement in the global rankings, indicating the strength and uniqueness of their patented technology.
Full safety information is available in the Instructions for Use and Clinician Portal Manual.
HeartBeam's unique approach involves capturing electrical signals in three noncoplanar dimensions and synthesizing them into a comprehensive 12-lead ECG, enabling portable remote cardiac monitoring that was previously only available in clinical settings.
Curated from InvestorBrandNetwork (IBN)
